Relative bioavailability of Neoral versus Sandimmune in the presence of a P450IIIA and P-glycoprotein inhibitor

被引：9
|
作者：
Choc, MG [1 ]
Mueller, EA
Robinson, WT
Kumle, A
Smith, HT
Charnick, SB
机构：
[1] Nova Pharmaceut Corp, E Hanover, NJ 07936 USA
[2] Novartis Pharma AG, Basel, Switzerland
来源：
TRANSPLANTATION PROCEEDINGS | 1998年 / 30卷 / 05期
关键词：
D O I：
10.1016/S0041-1345(98)00383-2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1664 / 1665
页数：2
相关论文
共 50 条
  • [1] CYCLOSPORINE METABOLISM BY P450IIIA IN RAT ENTEROCYTES - ANOTHER DETERMINANT OF ORAL BIOAVAILABILITY
    KOLARS, JC
    STETSON, PL
    RUSH, BD
    RUWART, MJ
    SCHMIEDLINREN, P
    DUELL, EA
    VOORHEES, JJ
    WATKINS, PB
    TRANSPLANTATION, 1992, 53 (03) : 596 - 602
  • [2] CYCLOSPORINE IS METABOLIZED BY ENTEROCYTE P450IIIA INVIVO
    KOLARS, JC
    STETSON, PL
    RUSH, BD
    RUWART, MJ
    WATKINS, PB
    CLINICAL RESEARCH, 1991, 39 (02): : A222 - A222
  • [3] Substrate versus inhibitor dynamics of P-glycoprotein
    Ma, Jerome
    Biggin, Philip C.
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2013, 81 (09) : 1653 - 1668
  • [4] DEVELOPMENTAL ASPECTS OF P450IIIA - PRENATAL ACTIVITY AND INDUCIBILITY
    HULLA, JE
    JUCHAU, MR
    DRUG METABOLISM REVIEWS, 1989, 20 (2-4) : 765 - 779
  • [5] Enhanced bioavailability of oral paclitaxel by valspodar (PSC 833), an inhibitor of small bowel P-glycoprotein and cytochrome P450.
    Sikic, BI
    Advani, R
    Fisher, GA
    Halsey, J
    Cohen, P
    Lum, BL
    CLINICAL CANCER RESEARCH, 2000, 6 : 4580S - 4580S
  • [6] P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans
    Schwarz, UI
    Gramatté, T
    Krappweis, J
    Oertel, R
    Kirch, W
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2000, 38 (04) : 161 - 167
  • [7] The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice
    Rogier R. Press
    Tessa Buckle
    Jos H. Beijnen
    Olaf van Tellingen
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 819 - 825
  • [8] The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice
    Press, RR
    Buckle, T
    Beijnen, JH
    van Tellingen, O
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (06) : 819 - 825
  • [9] A GENE STRUCTURE OF TESTOSTERONE 6-BETA-HYDROXYLASE (P450IIIA)
    MIYATA, M
    NAGATA, K
    YAMAZOE, Y
    KATO, R
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 177 (01) : 68 - 73
  • [10] Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats
    Bansal, Tripta
    Mishra, Gautam
    Jaggi, Manu
    Khar, Roop K.
    Talegaonkar, Sushama
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 36 (4-5) : 580 - 590
12345